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In the initial stages of transendothelial migration, leukocytes use the endothelial integrin ligands ICAM-1 and VCAM-1 for strong
adhesion. Upon adhesion of the leukocyte to endothelial ICAM-1, ICAM-1 is clustered and recruited to the adhered leukocyte,
promoting strong adhesion. In this study, we provide evidence for the colocalization of VCAM-1 at sites of ICAM-1 clustering.
Anti-ICAM-1 antibody-coated beads were used to selectively cluster and recruit ICAM-1 on primary human endothelial cells. In
time, co-localization of ICAM-1 and VCAM-1 around the adherent beads was observed. Biochemical pull-down assays showed
that ICAM-1 clustering induced its association to VCAM-1, suggesting a physical link between these two adhesion molecules. The
association was partly dependent on lipid rafts as well as on F-actin and promoted adhesion. These data show that VCAM-1 can
be recruited, in an integrin-independent fashion, to clustered ICAM-1 which may serve to promote ICAM-1-mediated leukocyte
adhesion.
1.Introduction
Leukocytes migrate across endothelial monolayers to reach
sites of inﬂammation. As a result of many intensive and
detailed studies that have been carried out over the last 10–
15 years, it has become clear that the endothelium that lines
the vessel wall is actively involved in supporting leukocyte
transendothelial migration [1]. Upon binding of leukocytes
to the endothelium, Ig-like cell adhesion molecules (CAMs)
that are expressed on the apical surface of the endothelium,
are clustered, recruited to sites of leukocyte adhesion, and
concomitantly activated [2].
ThemainIg-likeCAMsonendotheliumareInterCellular
Adhesion Molecule-1 (ICAM-1/CD54) and Vascular Cell
Adhesion Molecule-1 (VCAM-1/CD106). ICAM-1 is consti-
tutively expressed at low levels on endothelial cells and 5- to
10-fold up-regulated upon stimulation with inﬂammatory
mediators such as IL1β and TNFα [2, 3]. Leukocytes bind
through their integrins LFA-1/Mac-1 to the extracellular
domain of ICAM-1 [2]. Upon binding, ICAM-1 is clustered
into membrane rafts [4], small, highly dynamic, sterol-
and sphingo-lipid-enriched membrane rafts that can be
stabilized to form large platforms through protein-protein
interactions [5]. It has been reported that clustering of
ICAM-1 induces intracellular signalling in endothelial cells,
resulting in rearrangement of the actin cytoskeleton [2, 6, 7].
In line with this, binding of leukocytes through ICAM-1
inducesalocalincreaseinF-actincontentatsitesofadhesion
[6].
VCAM-1 is weakly expressed on resting endothelium
but is highly up-regulated upon stimulation with inﬂam-
matory mediators [2, 3]. Leukocytes adhere through the
integrin VLA-4 to VCAM-1 on the endothelium. Similar
as for ICAM-1, clustering of VCAM-1 induces intracellular
signalling, leading to ROS production, p38 phosphorylation,
and protein tyrosine phosphatase 1B activation [8, 9].
Barreiro and colleagues showed that the presence of the
tetraspanins CD9 and CD151 is required for optimal adhe-
sivefunctionsofICAM-1andVCAM-1[10].Clearly,binding
of leukocytes to either ICAM-1 or VCAM-1 induces multiple
eﬀects in the endothelium most of which serve to promote
the interaction between the leukocyte and the endothelium
as well as the subsequent transendothelial migration.2 Journal of Biomedicine and Biotechnology
Our data presented here indicate that VCAM-1 is
recruited to sites of ICAM-1-induced adhesion independent
of VCAM-1-binding to its cognate receptor; VLA-4. Bio-
chemical studies showed that ICAM-1 clustering induces
a physical association with VCAM-1. Using ﬂuorescence
microscopy, we demonstrate that VCAM-1 is recruited to
clustered ICAM-1 in a time-dependent fashion. These data
indicate that ICAM-1 and VCAM-1 co-operate to facilitate
the adhesion and extravasation of leukocytes.
2.MaterialandMethods
2.1. Reagents and Antibodies. The following antibodies (Ab)
were used: mAb against ICAM-1 (84H10); ICAM-1-FITC;
VCAM-1 (1G11) from R&D systems (Minneapolis, MN,
USA); pAb against ICAM-1 (H-108) and VCAM-1 (C-
19) from Santa Cruz Biotechnology (Heerhugowaard, The
Netherlands); mAb against PECAM-1 (CD31) and isotype
control IgG from Sanquin Immunoreagents (Amsterdam,
The Netherlands); Alexa488-labelled cαm, Alexa488 cαr;
Alexa-594 cαm; Alexa-594 cαr and Alexa647 cαgf r o m
Invitrogen (Leiden, The Netherlands). For actin staining
Bodipy650/665 phalloidin and Texas Red-X phalloidin were
used (Invitrogen).
2.2. Cell Cultures. HUVECs were obtained from Cambrex
(East Rutherford, NJ) and cultured as described previously
in in [11]. Endothelial cells were activated with 10ng/mL
TNFα(R&Dsystems)overnight,tomimicinﬂammationand
grown to conﬂuent monolayers over at least 3 days. HeLa
cells were routinely cultured in IMDM supplemented with
10% FCS and 5% glutamine. All cell lines were cultured or
incubated at 37◦Ca t5 %C O 2.
2.3. Immunoﬂuorescent Imaging. HUVECs were cultured on
FN-coated glass coverslips, ﬁxed, and immunostained as
described in [11] and stained for proteins as indicated, fol-
lowed by secondary ﬂuorescently labelled Abs. Images were
recorded with a ZEISS LSM510-Meta confocal microscope
(Carl Zeiss, Jena, Germany) with appropriate ﬁlter settings.
Cross-talk between the green and red channel was avoided
by use of sequential scanning.
2.4. Coating of Beads. Magnetic gαm IgG Ab-coated Dyn-
abeads (Invitrogen) were coated with ICAM-1, VCAM-1 or
IgG isotype control mAbs according to the manufacturers’
protocol. Polystyrene 10μma n d3 μm beads (Polysciences
Inc., Eppelheim, Germany) were coated with antibody
according to the manufacturer’s instructions and used for
immunoﬂuorescent imaging.
2.5. Adhesion of Beads. HeLa cells were cultured on FN-
coated glass coverslips and transfected with ICAM-1-
mCherry or VCAM-1-GFP or a combination. Next, ICAM-
1c o a t e db e a d sw e r ea l l o w e dt oa d h e r et ot h ec e l l sf o r3 0
minutes at 37◦Ca t5 %C O 2, after which the cells were put
on ice and gently washed three times with ice-cold PBS,
containing 1mM CaCl2 and MgCl2. Then, samples were
ﬁxed and immunostained for F-actin as described in [11].
Beadsthatadheredtopositive transfectedcellswerecounted.
2.6. Protein Crosslinking. Crosslinking experiments were
c a r r i e do u ta sd e s c r i b e di n[ 11]. Brieﬂy, HUVEC were
treated with mouse-antihuman antibody against a protein
as indicated for 30 minutes, washed to remove all the non-
bound Abs and subsequently incubated for an additional 30
minutes with goat-antimouse IgG antibodies that crosslink
mouse-antihuman Abs through their Fc-tail. This results in
clustering of the protein of interest.
2.7. Immunoprecipitation and Western Blot Analysis. Cells
were grown to conﬂuency on FN-coated dishes (50cm2),
washed twice gently with ice-cold Ca2+-a n dM g 2+-
containing PBS, and lysed in 300μLo fl y s i sb u ﬀer (25mM
Tris, 150mM NaCl, 10mM MgCl2,2m ME D T A ,1 %T r i t o n
X-100, with the addition of fresh protease-inhibitor-cocktail
tablets (Boehringer) pH 7.4). After 10 minutes on ice,
cell lysates were collected and precleared for 30 minutes
at 4◦C with Protein-G Sepharose beads (GE Healthcare,
Sweden; 15μL for each sample). The supernatant, cleared by
centrifugation (14.000∗g, 5 minutes at 4◦C) was incubated
with 15μlp r o t e i nS e p h a r o s eb e a d st h a tw e r ec o a t e dw i t ht h e
Ab of interest for 1 hour at 4◦C under continuous mixing.
The beads were washed 3 times in lysis buﬀer and proteins
were eluted by boiling in SDS-sample buﬀer containing 4%
2-mercaptoethanol.Thesampleswereanalyzedby10%SDS-
PAGE. Proteins were transferred to 0.45μm nitro-cellulose
(Schleicher and Schnell Inc., NH) and the blots were ﬁrst
blocked with 5% (w/v) low-fat milk in Tris-Buﬀered Saline
Tween-20 (TBST) for 1 hour, subsequently incubated at
room temperature with the appropriate Abs for 1 hour,
followed by 30 minutes incubation with HRP-conjugated
secondary Abs at RT. Between the various incubation steps,
the blots were washed 5 times with TBST and ﬁnally
developed with an enhanced chemiluminescence (ECL)
detection system (Amersham).
2.8.Statistics. StudentsT-testwasusedtocalculatestatistical
signiﬁcance.
3. Results
Upon inﬂammation, not only the expression of ICAM-1 but
also of VCAM-1 is increased, up to 20-fold [2, 3]. ICAM-1
and VCAM-1 hardly colocalize with each other on TNFα-
treated endothelial cells (Figure 1(a)). ICAM-1 localizes
more to the periphery of the cell, and VCAM-1 staining was
more pronounced at the cell-body (Figure 1(a)). Detailed
analysis showed however that VCAM-1 did co-localize to
some extent with ICAM-1 in microvilli, but we found no co-
localization at the baso-lateral side of the cells (Figure 1(b)).
To address leukocyte-induced coclustering of ICAM-1 and
VCAM-1, we made use of HL60 cells, which were diﬀeren-
tiated towards a neutrophil-like, myeloid-lineage cell typeJournal of Biomedicine and Biotechnology 3
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Figure 1: ICAM-1 and VCAM-1 localization in TNFα-stimulated endothelial cells. (a) TNFα-treated HUVECs were ﬁxed and stained as
indicated. Bar, 20μm. (b) Detailed analysis of ICAM-1 and VCAM-1 co-localization at the apical surface (arrowheads) in TNFα-treated
endothelial cells that were ﬁxed and stained as indicated. Bar, 10μm. (c) Diﬀerentiated HL60 cells were allowed to adhere to TNFα-
treated HUVECs for 30 minutes, after which cells were ﬁxed and stained as indicated. Apical focal plane shows that ICAM-1 and VCAM-1
(arrowheads) are recruited around adhered HL60 cells (asterisks). Bar, 10μm.4 Journal of Biomedicine and Biotechnology
using 1.3% DMSO. These cells express all required integrins
to bind to ICAM-1 or VCAM-1, that is, LFA-1, Mac-1, and
VLA-4 (data not shown). Following seeding of these cells
on activated endothelial cells, we found that both adhesion
molecules were recruited around ﬁrmly adherent leukocytes,
aswasalsodescribedbyBarreiroetal.[12](Figure 1(c)).The
clustering of ICAM-1 and VCAM-1, induced by HL60 cells,
was also observed in human microvascular endothelial cells
(data not shown).
In order to speciﬁcally focus on ICAM-1-mediated
adhesion, we used anti-ICAM-1 antibody-coated beads,
hereafter called ICAM-1 beads that induce clustering of
ICAM-1 on the surface of TNFα-treated endothelial cells.
Within 10 minutes, endogenous ICAM-1 was recruited to
sitesofbeadadhesion,asdeterminedbyconfocalmicroscopy
using FITC-conjugated ICAM-1 antibodies (Figure 2(a)).
As a negative control, anti-MHC class I-antibody coated
beads or anti-IgG antibody coated beads were used. No
recruitment of ICAM-1 could be observed using these beads
(data not shown). Costaining for VCAM-1 showed that, in
time, VCAM-1 also was recruited to adhesion sites that were
induced by ICAM-1 beads, although no VCAM-1 binding
antibodies were present (Figure 2(a)). Detailed X-Z analysis
showed that ICAM-1 and VCAM-1 are both accumulating
in the membrane structure around adhered ICAM-1 beads
(see Figure 1in Supplementary Material available online
at doi:10.1155/2010/120328 ). Quantiﬁcation of VCAM-
1-recruitment to membrane around these anti-ICAM-1-
antibody coated beads showed that at 60 minutes, more
than 80% of the beads recruited, next to ICAM-1, also
VCAM-1 (Figure 2(b)). Additional experiments in which the
time course was extended to 120 minutes showed that the
percentage of co-localization between ICAM-1 and VCAM-
1 around the beads did not change. Conversely, using anti-
VCAM-1-antibody coated beads, hereafter called VCAM-1
beads, seeded on TNFα-treated endothelial cells we could
demonstrate that after 60 minutes, ICAM-1 was recruited
to clustered VCAM-1 (Figure 2(c)). These data suggest that
ICAM-1 and VCAM-1 associate upon clustering of either
integrin ligand.
To investigate this further, we used ICAM-1-antibody
coated magnetic beads to cluster ICAM-1 on the surface
of the endothelium, followed by a pull-down assay from
the cell lysates. Interestingly, these experiments showed that
VCAM-1 associated to the ICAM-1 beads (Figure 3(a)). As
controls,weshowthatVCAM-1beadseﬃcientlyprecipitated
VCAM-1 from endothelial cell lysates; whereas anti-IgG1-
antibody coated beads were unable to precipitate VCAM-
1( Figure 3(a)). Vice versa, endogenous ICAM-1 was pre-
cipitated with VCAM-1 beads from endothelial cell lysates
(Figure 3(b)), albeit less eﬃcient than the pull-down using
ICAM-1 beads (compare with Figure 3(a)). As a control,
we used anti-IgG1-antibody coated beads which did not
precipitate ICAM-1 (Figure 3(b)). To study if clustering of
ICAM-1 promotes the association with VCAM-1, ICAM-
1 antibodies in solution were used to crosslink ICAM-
1 on the surface of the endothelium. This method has
been used extensively by many groups including ours [2,
4, 7, 11]. Subsequently, the cells were lysed and ICAM-1
was immunoprecipitated from the cell lysate. The results,
presented in Figure 3(c), showed that VCAM-1 association
with ICAM-1 is stimulated when ICAM-1 is clustered,
that is, upon crosslinking. ICAM-1 immunoprecipitation
following cross-linking of MHC-class I molecules did not
promote association of VCAM-1 (Figure 3(c)). To show that
ICAM-1 is speciﬁcally precipitated by ICAM-1 beads and
not by anti-MHC class I-antibody coated beads, pull-down
assays were performed and analyzed for the presence of
ICAM-1. The results showed that ICAM-1- but not anti-
MHC-antibody coated beads precipitated ICAM-1 from
endothelial cell lysates (Figure 3(d)). In addition, anti-
PECAM-1-antibody coated beads, which cluster of PECAM-
1, did not precipitate ICAM-1 (Figure 3(e)). These data
indicatethatICAM-1andVCAM-1physicallyassociateupon
clustering.
Previous literature suggests that ICAM-1 shifts to lipid-
rafts upon clustering [4]. To investigate if the association
between ICAM-1 and VCAM-1 depends on lipid raft forma-
tion, TNFα-stimulated endothelial cells were pretreated with
the cholesterol chelator cyclodextrin (CD). Using ICAM-
1 beads on endothelial cells, the recruitment of VCAM-
1 after 60 minutes of adhesion showed a reduction of
approximately 30% of VCAM-1 recruitment to ICAM-
1-positive adhesive sites (Figure 4(a)). To study if actin
polymerization is required for the recruitment of VCAM-
1 to ICAM-1 beads, endothelial cells were pre-treated
with Cytochalasin B. Quantiﬁcation showed that after 60
minutes, VCAM-1 was less eﬃciently recruited to ICAM-
1 beads when actin polymerization was blocked. Thus,
actin polymerization is required for optimal recruitment of
VCAM-1 to ICAM-1-induced adhesion sites (Figure 4(a)).
To study if VCAM-1 had an additional eﬀect on ICAM-
1-induced adhesion sites, ICAM-1 beads were allowed to
adhere for 60 minutes to HeLa cells that were transfected
with GFP, ICAM-1-mCherry, VCAM-1-GFP, or double-
transfected with ICAM-1-mCherry and VCAM-1-GFP. The
results showed that ICAM-1 beads eﬃciently adhered to
ICAM-1-mCherry expressing cells (2 ± 0.5 ICAM-1 beads
per ICAM-1-mCherry-positive cell) but not to VCAM-1-
GFP or GFP expressing cells (Figure 4(b)). Interestingly, a
signiﬁcant increase in adhesion of ICAM-1 beads to the
cells was measured when ICAM-1 and VCAM-1 were both
expressed (3.25 ± 0.7 ICAM-1 beads per ICAM-1-mCherry-
positive cell) (Figure 4(b)). Using VCAM-1 beads, similar
results were obtained as for the ICAM-1 beads (Figure 4(c)).
In addition, non-diﬀerentiated HL60 cells that express (in
contrast to diﬀerentiated HL60 cells) primarily LFA-1, the
counter-receptor for ICAM-1, and low levels of beta-1
integrin, and U937 cells that express primarily VLA-4, the
counter-receptor for VCAM-1 were used in the same set-
up as described for Figures 4(b) and 4(c). Interestingly,
also the adhesion of these cells to double-transfected cells
was increased (Figure 4(d)). These data suggest that initial
leukocyte adhesion may be mediated by a single adhesion
molecule(e.g.,ICAM-1),butthatintime,whentheadhesion
sites mature, other transmembrane adhesion molecules such
as VCAM-1 are coclustered and assisted ICAM-1 in its
adhesive function.Journal of Biomedicine and Biotechnology 5
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Figure 2: VCAM-1 is recruited to anti-ICAM-1-antibody coated beads. (a) ICAM-1 beads (diameter 3μm) were allowed to adhere to TNFα-
treated HUVECs. Subsequently, the samples were ﬁxed at the indicated time points and stained as indicated. VCAM-1 is recruited to ICAM-
1 beads (arrowheads) in time. Bar, 10μm. (b) Quantiﬁcation of VCAM-1 recruitment to ICAM-1-induced adhesion sites. The number of
adhered ICAM-1-antibody beads that were positive for ICAM-1-FITC staining was set as 100% and percentage of beads that co-localized
with VCAM-1 was counted. At 60 minutes adhesion, approximately 80% of ICAM-1 beads that recruited ICAM-1 also recruited VCAM-1.
Data are mean ± SEM of three independent experiments. (c) VCAM-1 beads (diameter 3μm) were allowed to adhere to TNFα-treated
HUVECs and stained as indicated. ICAM-1 is recruited to VCAM-1 beads (arrowheads). Bar, 10μm.6 Journal of Biomedicine and Biotechnology
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Figure 3:VCAM-1associateswithclusteredICAM-1.(a)BeadswerecoatedwiththeindicatedAbsasdescribedinSection 2andsubsequently
incubated with lysates from TNFα-treated HUVECs, followed by centrifugation, washing and analysis of bound proteins by SDS-PAGE and
Western blotting. Blots were stained for VCAM-1 and show that VCAM-1 was precipitated with VCAM-1 beads and also with ICAM-1
beads. No VCAM-1 was detected in pull-downs using anti-IgG antibody coated beads. Lower panel shows expression of VCAM-1 in cell
lysates as a loading control. Data are representative for three experiments. (b) The pull-down experiment was carried out as described under
(a) and blots were stained for ICAM-1. ICAM-1 was precipitated with ICAM-1 beads, and a fraction of ICAM-1 associates with VCAM-1
beads, albeit less eﬃcient than the reciprocal experiment shown in (a). No ICAM-1 was detected in pull-down experiments using anti-IgG
coated beads. Lower panel shows expression of ICAM-1 as loading control in cell lysates. Data are representative for three experiments.
(c) TNFα-stimulated HUVECs were incubated with ICAM-1 Ab in solution for 30 minutes and subsequently crosslinked with secondary
antimouse Ab for an additional 30 minutes. Cells were lysed and ICAM-1 was immunoprecipitated and analyzed by Western blotting, which
shows that ICAM-1-clustering induced association with VCAM-1. Lower panel shows ICAM-1 expression in cell lysates. Bottom panel
shows that crosslinking of MHC class I protein did not induce any binding of VCAM-1. (d) ICAM-1 is precipitated by ICAM-1 beads, but
not by anti-MHC class I antibody coated beads. Lower panel shows expression of ICAM-1 in cell lysates. (e) No ICAM-1 is precipitated by
anti-PECAM-1 antibody coated beads (upper panel). Lower panel shows precipitation of PECAM-1 with the beads.
4. Discussion
Members of the Ig-like superfamily of cell adhesion
molecules such as ICAM-1 and VCAM-1 are key players
in the process of inﬂammation. Upon stimulation with
inﬂammatory cytokines such as TNFα and IL1β, these
adhesion molecules are highly upregulated and support the
migration ofleukocytes to sites ofinfection or inﬂammation.
Both adhesion molecules have speciﬁc counter-receptors:
ICAM-1 binds the integrins LFA-1 and Mac-1, expressed
on most leukocytes and VCAM-1 interacts with VLA-4,
expressed on monocytes. It is believed that these interactions
can occur in parallel. Our group has shown that blocking
either ICAM-1 or VCAM-1 with antibodies reduces the
migration of hematopoietic stem cells across endothelial
monolayers in [11]. Blocking both molecules decreased stem
cell transmigration in an additive fashion in [11]. In the
present study, we show that ICAM-1 clustering recruits
VCAM-1 and vice versa, independent from their cognate
receptor and in a time-dependent fashion.
Additionally, we show that this recruitment partially
depends on the presence of lipid-rafts that have previously
been implicated in adhesion receptor clustering [4]a n d
promote ICAM-1-adhesive function. Our data suggest that
the clustering of transmembrane adhesion molecules by
adherent leukocytes provides a platform recruiting other
molecules to form a multiprotein complex that will assist
leukocytes to adhere to and migrate across the endothelial
monolayer. However, Ig-like CAM CD31/PECAM-1 appears
nottoparticipateintheformationoftheseplatforms,atleastJournal of Biomedicine and Biotechnology 7
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Figure 4: ICAM-1-induced VCAM-1 recruitment depends on lipid-rafts and actin polymerization and promotes ICAM-1-induced adhesion. (a)
Anti-ICAM-1-antibody coated beads were allowed to adhere for 60 minutes to TNFα-stimulated HUVECs that were left untreated (CTRL)
or were pretreated for 30 minutes with either cyclodextrin (CD; 3.8μM) or cytochalasin B (CytoB; 1μg/mL). Subsequently, cells were ﬁxed
and immunostained with ICAM-1-FITC and VCAM-1 Abs. VCAM-1 recruitment to ICAM-1 beads was quantiﬁed which showed that close
to 80% of ICAM-1 beads which recruited ICAM-1 (set as 100%) also recruited VCAM-1. CD pretreatment reduced VCAM-1 recruitment
with 40% and CytoB with 50%. Experiment was carried out three times. Data are mean ± SEM. ∗P<. 05. (b) Anti-ICAM-1-antibody coated
beads were allowed to adhere for 60 minutes to HeLa cells that were transfected as indicated. Subsequently, cells were ﬁxed and analyzed by
confocal microscopy for number of ICAM-1 beads that adhered to one transfected cell. 50 transfected cells per experiment were analyzed
and the experiment is carried out in duplicate. The experiment was carried out three times. Data are mean ± SEM. ∗P<. 05. (c) Anti-
VCAM-1-antibody coated beads were allowed to adhere for 60 minutes to HeLa cells that were transfected as indicated. Subsequently, cells
were ﬁxed and analyzed by confocal microscopy for number of VCAM-1 beads that adhered to one transfected cell. 50 transfected cells per
experimentwereanalyzedandtheexperimentiscarriedoutinduplicate.Theexperimentwascarriedoutthreetimes.Dataaremean ±SEM.
∗P<. 05. (d) Nondiﬀerentiated HL60 or U937 cells were allowed to adhere for 60 minutes to HeLa cells that were transfected as indicated.
Subsequently, cells were ﬁxed and analyzed by confocal microscopy for number of VCAM-1 beads that adhered to one transfected cell. 50
transfected cells per experiment were analyzed and the experiment is carried out in duplicate. The experiment was carried out two times.
Data are mean ± SEM. ∗P<. 05.8 Journal of Biomedicine and Biotechnology
notinthoseinducedbyICAM-1-VCAM-1,aswedidnotﬁnd
any detectable PECAM-1 in the ICAM-1- or VCAM-1-based
pull-downs.
ERM-proteins (i.e., ezrin, radixin, and moesin) are
adaptor proteins that bind the actin cytoskeleton and have
been found to associate to either ICAM-1 or VCAM-1 [12].
However, we have not found an interaction between one of
the ERM-proteins and the intercellular tail of ICAM-1 or
VCAM-1 (personal observation JDvB and JvR). Therefore,
theERM-familyproteinsaremostlikelynottheintermediate
adapterproteins thatlink ICAM-1 toVCAM-1. Interestingly,
ICAM-1 intracellular tail contains two SH3-type domains;
whereas the VCAM-1 intracellular tail harbours a PDZ-
bindingdomainatitsveryend[13].Therefore,aproteinthat
is rich in prolines and also carries a PDZ domain may be a
candidate to link ICAM-1 and VCAM-1 directly.
It is appreciated that ICAM-1 recruits several intracel-
lular signalling and adaptor proteins upon clustering (see
for review [2, 6]). Nevertheless, to our knowledge, it has
never been shown that ICAM-1 can actively recruit other
transmembrane adhesion molecule family members upon
clustering. The previous papers have reported that neuronal-
(N-) CAM, a family member of the endothelial CAMs,
recruits FGFR-4 and N-cadherin in L-cells [14]. These
authors also showed that the signalling molecule Src-kinase
and the actin-linker protein cortactin are present in the same
complex with N-CAM. Src and cortactin are also found in
relation to ICAM-1 function: antibody-induced crosslinking
of ICAM-1 or clustering of ICAM-1 using anti-ICAM-1-
antibody coated beads induces the activation of Src [15–
17]. Along this line, ICAM-1 may serve, like N-CAM, as
a docking site for proteins, not only intracellular but also
transmembrane proteins.
Interestingly, Barreiro and coworkers recently reported
the existence of so-called “endothelial adhesive platforms”
(EAPs). These platforms are composed of small, tetraspanin-
enriched microdomains that express ICAM-1 and VCAM-
1[ 18]. The clustering of ICAM-1 and VCAM-1 in these
EAPs is independent of integrin engagement and the actin
cytoskeleton. Our data are in line with the report by Barriero
and coworkers and show that ICAM-1 and VCAM-1 co-
localize upon clustering of these proteins by antibody-coated
beads. Thus, concentrating either ICAM-1 or VCAM-1 may
lead to a clustering of nearby EAPs, resulting in further
increasing the local concentration of ICAM-1 and VCAM-1
at these sites.
A platform for protein complexes is an eﬃcient way to
controlandmergeseveralsignallingpathways[18–20].These
protein platforms involve tetraspanins: small palmitoylated
polypeptides that span the plasma membrane four times
[18, 21, 22]. Recently, it has been published that tetraspanins
play an important role in the function of the transmembrane
proteins ICAM-1 and VCAM-1 [18]. Other work from
Barreiro and co-workers shows that reduction of expression
levels of the tetraspanins CD9 and CD151 signiﬁcantly
reduces the adhesion capacities of ICAM-1 and VCAM-
1[ 10]. Moreover, blocking antibodies against endothelial
tetraspanin CD81 decreased the migration of monocytes
across endothelial monolayers [23]. These data indicate
that the formation of a tetraspanin-rich protein platform
is crucial for adhesion function and proper leukocyte
crossing. Our data indicated that coexpression of VCAM-
1 in ICAM-1-expressing monolayers did promote adhesion
of leukocytes. However, no signiﬁcant increase in neutrophil
transmigration under static conditions using HeLa cells
that expressed both ICAM-1 and VCAM-1 was measured,
compared to HeLa cells that only expressed ICAM-1-GFP
(data not shown).
Together, these results underscore the complexity of
the molecular events that accompany leukocyte adhesion
and transendothelial migration. Deﬁning the requirements
within the leukocytes and the endothelium, most likely
involving a combination of outside-in and inside-out sig-
nalling, warrant further research.
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